Inventor · disambiguated record
Michael Gormley
Also filed as: GORMLEY MICHAEL · GORMLEY MICHAEL P
1 granted patent·5 pending applications·0 citations·filing 2015–2023
1Inventor score
Files withJANSSEN PHARMACEUTICA NV6
Top patents by PatentIndex Score
6 records- 0154US2025170146A1Niraparib and abiraterone acetate plus prednisone to improve clinical outcomes in patients with metastatic castration-resistant prostate cancer and hrr alterationsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 0254US2024325369A1Treatment of metastatic castration-resistant prostate cancer with niraparibJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0343US2021115517A1Methods of treating prostate cancer based on molecular subtypesJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 0441US2020338057A1Methods of Treating Prostate Cancer Based on Molecular SubtypesJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 0534US2016304962A1WHOLE BLOOD BASED mRNA MARKERS FOR PREDICTING PROSTATE CANCER AND METHODS OF DETECTING THE SAMEJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 0632US11180809B2Biological markers for identifying patients for treatment with abiraterone acetateJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Nov 23, 2021·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Michael Gormley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →